Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms25042181 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Angelico D Aputen und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Science, Western Sydney University, Sydney, NSW 2751, Australia. Hauptthemen laut MEDLINE: Prodrugs, Antineoplastic Agents. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 142 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Australian Government Research Training Program Scholarship, Western Sydney University, Western Sydney University Australian Postgraduate Award.
Abstract (Originalsprache)
Kinetically inert platinum(IV) complexes are a chemical strategy to overcome the impediments of standard platinum(II) antineoplastic drugs like cisplatin, oxaliplatin and carboplatin. In this study, we reported the syntheses and structural characterisation of three platinum(IV) complexes that incorporate 5-benzyloxyindole-3-acetic acid, a bioactive ligand that integrates an indole pharmacophore. The purity and chemical structures of the resultant complexes, P-5B3A, 5-5B3A and 56-5B3A were confirmed via spectroscopic means. The complexes were evaluated for anticancer activity against multiple human cell lines. All complexes proved to be considerably more active than cisplatin, oxaliplatin and carboplatin in most cell lines tested. Remarkably, 56-5B3A demonstrated the greatest anticancer activity, displaying GI50 values between 1.2 and 150 nM. Enhanced production of reactive oxygen species paired with the decline in mitochondrial activity as well as inhibition of histone deacetylase were also demonstrated by the complexes in HT29 colon cells.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Science, Western Sydney University, Sydney, NSW 2751, Australia.
- Ingham Institute, Sydney, NSW 2170, Australia.
- Calvary Mater Newcastle Hospital, Newcastle, NSW 2298, Australia.
- School of Medicine, Western Sydney University, Sydney, NSW 2751, Australia.
ORCID-Profile: Angelico D Aputen, Jayne Gilbert, Jennette A Sakoff, Christopher P Gordon, Kieran F Scott, Janice R Aldrich-Wright
Förderung
- Australian Government Research Training Program Scholarship
- Western Sydney University
- Western Sydney University Australian Postgraduate Award
- The School of Science, Western Sydney University
Zitieren
APA
Aputen, A. D., Elias, M. G., Gilbert, J., Sakoff, J. A., Gordon, C. P., Scott, K. F., & Aldrich-Wright, J. R. (2024). Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms25042181
Vancouver
Aputen AD, Elias MG, Gilbert J, Sakoff JA, Gordon CP, Scott KF, et al. Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms25042181
BibTeX
@article{Aputen2024,
author = {Aputen, Angelico D and Elias, Maria George and Gilbert, Jayne and Sakoff, Jennette A and Gordon, Christopher P and Scott, Kieran F and Aldrich-Wright, Janice R},
title = {Platinum(IV) Prodrugs Incorporating an Indole-Based Derivative, 5-Benzyloxyindole-3-Acetic Acid in the Axial Position Exhibit Prominent Anticancer Activity},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms25042181}
}
EUVIMED